Successful xenografting of first trimester human fetal CNS tissue and retina has been reported in the literature. We wished to test the feasibility ofusing the anterior chamber ofthe rat eye to support the development of more mature human fetal xenografts. Here we report on the successful outcome of human brain and retinal transplants. Adult host rats immunosuppressed with cyclosporin A accepted these xenografts and supported their further development. Periodic examination of the host eyes using a direct ophthalmoscope or an ophthalmic slit lamp permitted direct visual monitoring of the health and growth of the transplants. Histologically it was possible to identify neuronal, macroglial, and microglial (macrophage) cell types within the grafts. Mitotic activity and histogenetic differentiation took place. Blood vessels filled with hematic cells were commonly present within the grafts. The walls of these vessels prevented the leakage ofhorseradish peroxidase, suggesting the presence of a functional brain-blood barrier in the graft. These results indicate that it is possible to use a small animal model to study normal and
INTRODUCTION
The use of the anterior chamber as a transplantation site was first attempted by van In addition, extensive research has been conducted in the area of syngeneic and xenogeneic grafting of CNS tissue, especially in the study of mechanisms of human brain development/8-11/. Olson 
METHODS

Host animals
The hosts for this study were 100-120 day old male Sprague-Dawley rats (Charles-River) of 200-350 gram body weight that were pathogen flee. The animals were housed in sterilized microisolator cages in a cubicle used for these studies only. They were maintained on an immunosuppressive regime utilizing cyclosporin A.
We determined that optimal results were obtained with a dose of 6 mg/kg i.m. one day prior to transplantation, followed by a maintenance dose of 5.0-6.0 mg/kg i.m. daily, adjusting the dose according to blood levels and serial weights. This resulted in cyclosporin A blood levels of 1000-1500 ng/ml using both monoclonal and polyclonal antibody detection assays.
Donor tissues
Procurement offetal tissues from elective therapeutic abortions was in 'strict accordance with scientific and ethical guidelines ofthe NIH and the University of Rochester. Consent for the use of fetal tissues in research was obtained by the obstetrician from the mother, although specific research projects were not des.ignated. The tissue used could not be identified by name, hence confidentiality was assured.
After vacuum extraction, the gestational age of the tissue was confirmed, using heel-to-toe measurements in comparison with standardized charts. Brain or retinal tissue from fetuses between 12 and 19 weeks gestation was used for these studies. The number of animals that received transplanted tissue at each gestational age were distributed as follows: 12 weeks gestation (n 24), 13 weeks gestation (n 9), 14 weeks gestation (n= 11), 15 Macrophotograph of a rat eye bearing a 14.5 weeks gestational age human retinal xenograft 30 days post-transplantation. The 5 ) and GFAP positive astroglia (Fig. 6) ; also a few RCA-1 positive "microglia" cells were seen.
It was usual to find an absence of inflammatory cells in the host anterior chamber, a finding in agreement with the clear ocular media observed during the in vivo examinations.
Electron microscopical analysis of the grafts revealed the presence of synaptic contacts (Fig. 7) and growth cones/16/ (Fig. 8) (Fig. 9) A corollary of the previous discussion is that second-trimester xenografts in the anterior chamber may prove to be the optimal model for the study of anatomical, physiological, and pathological phenomena associated with more advanced human gestation stages.
